Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
Molecular Cancer Therapeutics|April 9, 2026
Targeting NDUFS4 Disrupts Oxidative Phosphorylation and Induces Ferroptosis in Olaparib-Resistant Prostate CancerZachary A Schaaf, Shu Ning, Amy R Leslie, et al.
Communications Medicine|September 26, 2022
Activation of neural lineage networks and ARHGEF2 in enzalutamide-resistant and neuroendocrine prostate cancer and association with patient outcomesShu Ning, Jinge Zhao, Alan P Lombard, et al.
BJU International|May 18, 2018
Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancerJinge Zhao, Guangxi Sun, Banghua Liao, et al.
The Journal of Clinical Investigation|March 17, 2026
Targeting Wnt/β-Catenin and circadian regulator restores PRC2/EZH2 controlled chromatin bivalency and suppresses cell state diversityYatian Yang, Xiong Zhang, Varadha Balaji Venkadakrishnan, et al.
Nature Medicine|March 29, 2016
ROR-γ drives androgen receptor expression and represents a therapeutic target in castration-resistant prostate cancerJunjian Wang, June X Zou, Xiaoqian Xue, et al.
Journal of the National Cancer Institute|December 6, 2017
Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate CancerAlexander W Wyatt, Matti Annala, Rahul Aggarwal, et al.
Cancer Research|August 1, 2024
LX1 Dual Targets AR Variants and AKR1C3 in Advanced Prostate Cancer TherapyShu Ning, Cameron M Armstrong, Enming Xing, et al.
Nature Communications|August 5, 2024
Proteostasis perturbation of N-Myc leveraging HSP70 mediated protein turnover improves treatment of neuroendocrine prostate cancerPengfei Xu, Joy C Yang, Bo Chen, et al.
BJU International|June 29, 2021
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostateJinge Zhao, Guangxi Sun, Sha Zhu, et al.
Biorxiv : the Preprint Server for Biology|December 15, 2025
A clinical-stage oncology compound selectively targets drug-resistant cancersKaitlin Long, Debanjan Bhattacharjee, Samuel H Newman-Stonebraker, et al.
Pageof 15